Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
5.
Curr Probl Cardiol ; 49(1 Pt B): 102088, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37716542

RESUMO

Vascular disease is a common problem with high mortality all over the world. Apelin-13, a key subtype of apelin, takes part in many physiological and pathological responses via regulating many target genes and target molecules or participating in many signaling pathways. More and more studies have demonstrated that apelin-13 is implicated in the onset and progression of vascular disease in recent years. It has been shown that apelin-13 could ameliorate vascular disease by inhibiting inflammation, restraining apoptosis, suppressing oxidative stress, and facilitating autophagy. In this article, we sum up the progress of apelin-13 in the occurrence and development of vascular disease and offer some insightful views about the treatment and prevention strategies of vascular disease.


Assuntos
Peptídeos e Proteínas de Sinalização Intercelular , Doenças Vasculares , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/uso terapêutico , Doenças Vasculares/prevenção & controle
6.
Curr Probl Cardiol ; 49(1 Pt C): 102116, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37802168

RESUMO

Mpox, a novel epidemic disease, has broken out the period of coronavirus disease 2019 since May 2022, which was caused by the mpox virus. Up to 12 September 2023, there are more than 90,439 confirmed mpox cases in over 115 countries all over the world. Moreover, the outbreak of mpox in 2022 was verified to be Clade II rather than Clade I. Highlighting the significance of this finding, a growing body of literature suggests that mpox may lead to a series of cardiovascular complications, including myocarditis and pericarditis. It is indeed crucial to acquire more knowledge about mpox from a perspective from the clinical cardiologist. In this review, we would discuss the epidemiological characteristics and primary treatments of mpox to attempt to provide a framework for cardiovascular physicians.


Assuntos
COVID-19 , Doenças Cardiovasculares , Mpox , Miocardite , Pericardite , Humanos , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , COVID-19/epidemiologia , Pericardite/epidemiologia , Pericardite/etiologia , Pericardite/terapia
7.
Curr Probl Cardiol ; 49(1 Pt C): 102161, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37875209

RESUMO

ABCG1 is an essential protein involved in the efflux of intracellular cholesterol to the extracellular space, thus playing a critical role in reducing cholesterol accumulation in neighboring tissues. Bibliometric analysis pertains to the interdisciplinary field of quantitative examination of diverse documents using mathematical and statistical techniques. It integrates the investigation of structural and temporal patterns in academic publications with an exploration of subject focus and forms of uncertainty. This research paper examines the historical evolution, current areas of interest, and future development trends of ABCG1 through bibliometric analysis. This study aims to offer readers insights into the research status and emerging trends of ABCG1, thereby assisting researchers in the exciting field to explore novel research avenues. Following rigorous selection, research on ABCG1 has remained highly active over the past two decades. ABCG1 has even started to emerge in previously unrelated fields, such as the field of cancer research. According to the analysis conducted by Citespace, a lot of keywords and influential citations were identified. ABCG1 has been found to establish a connection between cancer and cardiovascular disease, highlighting their interrelationship. This review aims to assist readers who have limited familiarity with ABCG1 research in gaining a rapid understanding of its developmental trajectory. Additionally, it aims to offer researchers potential areas of focus for future studies related to ABCG1.


Assuntos
Membro 1 da Subfamília G de Transportadores de Cassetes de Ligação de ATP , Colesterol , Humanos , Colesterol/metabolismo
8.
Curr Probl Cardiol ; 49(1 Pt B): 102096, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37741601

RESUMO

Nuclear factor interleukin-3 (NFIL3), a proline- and acidic-residue-rich (PAR) bZIP transcription factor, is called the E4 binding protein 4 (E4BP4) as well, which is relevant to regulate the circadian rhythms and the viability of cells. More and more evidence has shown that NFIL3 is associated with different cardiovascular diseases. In recent years, it has been found that NFIL3 has significant functions in the progression of atherosclerosis (AS) via the regulation of inflammatory response, macrophage polarization, some immune cells and lipid metabolism. In this overview, we sum up the function of NFIL3 during the development of AS and offer meaningful views how to treat cardiovascular disease related to AS.


Assuntos
Aterosclerose , Interleucina-3 , Humanos , Fatores de Transcrição de Zíper de Leucina Básica/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA